These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28838155)

  • 1. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward poliomyelitis eradication in Nigeria.
    Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
    Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
    Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.
    Anya BM; Moturi E; Aschalew T; Carole Tevi-Benissan M; Akanmori BD; Poy AN; Mbulu KL; Okeibunor J; Mihigo R; Zawaira F
    Vaccine; 2016 Oct; 34(43):5187-5192. PubMed ID: 27396492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of Volunteer Community Mobilizers to Polio Eradication in Nigeria: The Experiences of Non-governmental and Civil Society Organizations.
    Duru JI; Usman S; Adeosun O; Stamidis KV; Bologna L
    Am J Trop Med Hyg; 2019 Oct; 101(4_Suppl):74-84. PubMed ID: 31760970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the polio programme to deliver primary health care in Nigeria: implementation research.
    Bawa S; McNab C; Nkwogu L; Braka F; Obinya E; Galway M; Mirelman AJ; Hammanyero KI; Safiyanu G; Chukwuji M; Ongwae K; Mkanda P; Corkum M; Hegg L; Tollefson D; Umar S; Audu S; Gunda H; Chinta M; Jean Baptiste AE; Bagana M; Shuaib F
    Bull World Health Organ; 2019 Jan; 97(1):24-32. PubMed ID: 30618462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduct of vaccination in hard-to-reach areas to address potential polio reservoir areas, 2014-2015.
    Bawa S; Shuaib F; Saidu M; Ningi A; Abdullahi S; Abba B; Idowu A; Alkasim J; Hammanyero K; Warigon C; Tegegne SG; Banda R; Korir C; Yehualashet YG; Bedada T; Martin C; Nsubuga P; Adamu US; Okposen B; Braka F; Wondimagegnehu A; Vaz RG
    BMC Public Health; 2018 Dec; 18(Suppl 4):1312. PubMed ID: 30541501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communications, Immunization, and Polio Vaccines: Lessons From a Global Perspective on Generating Political Will, Informing Decision-Making and Planning, and Engaging Local Support.
    Menning L; Garg G; Pokharel D; Thrush E; Farrell M; Kodio FK; Veira CL; Wanyoike S; Malik S; Patel M; Rosenbauer O
    J Infect Dis; 2017 Jul; 216(suppl_1):S24-S32. PubMed ID: 28838189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.
    Tevi-Benissan C; Okeibunor J; du Châtellier GM; Assefa A; Biey JN; Cheikh D; Eshetu M; Anya BP; Dao H; Nasir Y; Akanmori BD; Mihigo R
    J Infect Dis; 2017 Jul; 216(suppl_1):S66-S75. PubMed ID: 28838178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
    Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
    PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing information for decision-making in the Nigerian Polio Eradication Program, 2016-2020.
    Erbeto T; Bammeke P; Aregay A; Kamran Z; Ibrahim A; Usifoh N; Adamu U; Omotayo B; Braka F; Damisa E; Kazadi W; Shuaib F
    Pan Afr Med J; 2023; 45(Suppl 2):11. PubMed ID: 38370106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014-2015.
    Hammanyero KI; Bawa S; Braka F; Bassey BE; Fatiregun A; Warigon C; Yehualashet YG; Tegene SG; Banda R; Korir C; Erbeto TB; Chukwuji M; Mkanda P; Adamu US; Nsubuga P
    BMC Public Health; 2018 Dec; 18(Suppl 4):1306. PubMed ID: 30541514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.
    Ramirez Gonzalez A; Farrell M; Menning L; Garon J; Everts H; Hampton LM; Dolan SB; Shendale S; Wanyoike S; Veira CL; Châtellier GMD; Kurji F; Rubin J; Boualam L; Chang Blanc D; Patel M
    J Infect Dis; 2017 Jul; 216(suppl_1):S183-S192. PubMed ID: 28838179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria.
    Lengkat FA; Chukwudozie OS; Vincent OO; James DM; Amina HG; Kenneth O
    Pan Afr Med J; 2019; 34():183. PubMed ID: 32158512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.